<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01743066</url>
  </required_header>
  <id_info>
    <org_study_id>BSMMU-004-CT</org_study_id>
    <nct_id>NCT01743066</nct_id>
  </id_info>
  <brief_title>Vitamin E Level in Buccal Cells of Arsenicosis Patients</brief_title>
  <official_title>Vitamin E Level in Buccal Cells of Arsenicosis Patients Following Vitamin E Supplementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To understand the pathogenesis of chronic arsenic toxicity, the investigators need to know&#xD;
      the levels of vitamin E in patients chronically exposed to high concentration of arsenic and&#xD;
      if changes are found, what happens when supplemented with vitamin E. The buccal cells and&#xD;
      serum of patients will be collected for the estimation of vitamin E both before and after&#xD;
      supplementation with vitamin E. Similar samples will be collected from similar number of&#xD;
      arsenic exposed controls and healthy volunteers for comparison.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic consumption of arsenic through water (drinking and cooking) and food leads to&#xD;
      accumulation of arsenic within the cell. We usually give emphasis on the skin manifestations&#xD;
      (melanosis and keratosis) of arsenicosis that is diagnosed first. Other manifestations remain&#xD;
      un-diagnosed or diagnosed later. The severe form is the development of cancer in different&#xD;
      organs mainly skin, lungs and urinary bladder. To understand the pathophysiology of the&#xD;
      development of clinical manifestations appearing in the skin first, we need to understand&#xD;
      interior of cells other than skin. One of the dietary supplements, vitamin E is found to be&#xD;
      effective in improving the clinical signs/symptoms of melanosis and keratosis. Buccal cells&#xD;
      are also exposed to arsenic and easy to collect. To understand the pathogenesis, we need to&#xD;
      know the levels of vitamin E in patients of arsenicosis and if changes, what happens when&#xD;
      supplemented with vitamin E. The buccal cells and serum of 20 patients will be collected for&#xD;
      the estimation of vitamin E both before and after supplementation with vitamin E (200 IU,&#xD;
      caplet) daily orally for 20 weeks. Similar samples will be collected from 20 arsenic exposed&#xD;
      controls and 20 healthy volunteers for comparison.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the amount of vitamin E in buccal cells</measure>
    <time_frame>0 week (baseline), 20 weeks (end)</time_frame>
    <description>Changes in the amount of vitamin E in buccal cells of arsenicosis patients, arsenic exposed controls and healthy volunteers will be estimated both before and after supplementation with vitamin E for 20 weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in the amount of cholesterol in buccal cells</measure>
    <time_frame>0 week (baseline), 20 weeks (end)</time_frame>
    <description>Changes in the amount of cholesterol in buccal cells of arsenicosis patients, arsenic exposed controls and healthy volunteers will be estimated both before and after supplementation with vitamin E for 20 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the concentration of vitamin E in serum</measure>
    <time_frame>0 week (baseline), 20 weeks (end)</time_frame>
    <description>Changes in the concentration of vitamin E in serum of arsenicosis patients, arsenic exposed controls and healthy volunteers will be estimated both before and after supplementation with vitamin E for 20 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the concentration of cholesterol in serum</measure>
    <time_frame>0 week (baseline), 20 weeks (end)</time_frame>
    <description>Changes in the concentration of cholesterol in serum of arsenicosis patients, arsenic exposed controls and healthy volunteers will be estimated both before and after supplementation with vitamin E for 20 weeks.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Chronic Arsenic Poisoning</condition>
  <arm_group>
    <arm_group_label>Arsenicosis patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin E (200 IU, caplet) daily orally for 20 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arsenic exposed controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>vitamin E (200 IU, caplet) daily orally for 20 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heathy volunteers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamin E (200 IU, caplet) daily orally for 20 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin E</intervention_name>
    <description>vitamin E (200 IU, caplet) daily orally for 20 weeks</description>
    <arm_group_label>Arsenic exposed controls</arm_group_label>
    <arm_group_label>Arsenicosis patients</arm_group_label>
    <arm_group_label>Heathy volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        For arsenicosis&#xD;
&#xD;
          -  who drank arsenic contaminated water (&gt;50 µg/L) for more than 6 months&#xD;
&#xD;
          -  having physical signs of moderate degree of melanosis and keratosis&#xD;
&#xD;
        For arsenic exposed control&#xD;
&#xD;
          -  relative or family member of the patient&#xD;
&#xD;
          -  showing no physical signs of melanosis and keratosis&#xD;
&#xD;
          -  share same tube well water for drinking purpose for more than 6 months&#xD;
&#xD;
        For healthy volunteers&#xD;
&#xD;
          -  who drank arsenic safe water (&lt;50 µg/L)&#xD;
&#xD;
          -  live in the same Upazilla&#xD;
&#xD;
          -  have no cutaneous manifestation&#xD;
&#xD;
          -  who voluntarily agree to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  tuberculosis, eczema psoriasis, contact dermatitis&#xD;
&#xD;
          -  patients getting treatment of arsenicosis&#xD;
&#xD;
          -  subject who voluntarily do not agree to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <study_first_submitted>December 1, 2012</study_first_submitted>
  <study_first_submitted_qc>December 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2012</study_first_posted>
  <last_update_submitted>December 4, 2012</last_update_submitted>
  <last_update_submitted_qc>December 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh</investigator_affiliation>
    <investigator_full_name>Prof. Mir Misbahuddin</investigator_full_name>
    <investigator_title>Prof. and Chairman</investigator_title>
  </responsible_party>
  <keyword>Arsenic</keyword>
  <keyword>Arsenicosis</keyword>
  <keyword>Buccal cells</keyword>
  <keyword>Serum</keyword>
  <keyword>Vitamin E</keyword>
  <keyword>Cholesterol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arsenic Poisoning</mesh_term>
    <mesh_term>Poisoning</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin E</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

